Ogden Christopher sold CTMX
March 19, 2024 · Form 4 insider transaction
Ogden Christopher sold 2,971 shares of CytomX Therapeutics, Inc. at $2.09 per share, a transaction worth $6.2K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Disposed (sell-side)
Shares
2,971
Price
$2.09
Total value
$6.2K
InsiderOgden Christopher
RoleOfficer
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateMarch 19, 2024
Filing dateMarch 21, 2024
Shares owned after85,686
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The shares were sold solely to satisfy tax or other government withholding obligations in connection with the vesting of restricted stock units.; Includes 60,310 restricted stock units.